Tokyo, 108-8642, Japan
NCT Number: NCT00719758
Drug-Drug Interaction Study of TRK-100STP
The purpose of this study is to evaluate the effect of AST-120 on the PK of TRK-100STP, and to evaluate the safety and tolerability of TRK-100STP alone or in combination with AST-120
Looking for future studies?
Notify MeKey information
Conditions
Age range
20 year–44 year
Sex eligibility
Male
Study type
Interventional
Phase
Phase 1
Primary location
About this study
Non-blinded, randomized and crossover study to evaluate pharmacokinetic interaction between TRK-100STP and AST-120 in different administration condition. Nonelderly adult volunteers will receive TRK-100STP with or without AS-T120 after meal. Safety parameters will concurrently be measured.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Provision of written informed consent
- Body Mass Index (BMI) of ≥17.6 to ≤26.4 kg/m2 and weight of ≥50 to ≤80 kg
Exclusion criteria
- Clinical abnormal physical findings, including BP, pulse rate, ECG and laboratory assessments
- Receives any investigational medicine within 120 days before screening
- Recent blood donor
Treatment and study plan
TRK-100STP (BERASUS LA)
Drugoral
Other names: beraprost, Careload LA, BERASUS LA
AST-120 (Kremezin®)
Drugoral
Other names: Kremezin®, sopherical carbon adsorbent
Primary outcomes
-
Pharmacokinetic profile
Time frame: 1 day
Secondary outcomes
-
Safety parameters (vital signs, ECG, laboratory tests)
Time frame: 1 day
Sponsors and collaborators
Lead sponsor
Astellas Pharma Inc
Industry
Collaborators
- Toray Industries, Inc
Registry information
Official study title
TRK-100STP Pharmacokinetic Study in Healthy Volunteers - Evaluation of Pharmacokinetic Interaction Between TRK-100STP and Kremezin
Important dates
- Study start
- 2008
- Primary completion
- 2008
- Study completion
- 2008
- First posted
- Jul 22, 2008
- Registry last updated
- Oct 13, 2008
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Tumor-Derived FGF19
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsAI Chatbot for HPV Vaccine Literacy Among Caregivers in Japan
NCT06702423
Healthy
London, United Kingdom
View Trial DetailsValidation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular Disease
NCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNormative Value for Navicular Drop Test in Older Adults
NCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details